Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
EpiVacCorona
Approved (Russia) Experimental Vaccine Oct/15/2020
E-M peptide
Potential treatment - theoretical effect Experimental Antiviral Oct/14/2020
Ramipril benzyl ester
Potential treatment - theoretical effect Experimental Antiviral Oct/06/2020
Propafenone dimer
Potential treatment - theoretical effect Experimental Antiviral Oct/06/2020
L2 Azo imidazole
Potential treatment - theoretical effect Experimental Antiviral Oct/02/2020
L1 Azo imidazole derivative
Potential treatment - theoretical effect Experimental Antiviral Oct/02/2020
L4 Azo imidazole derivative
Potential treatment - theoretical effect Experimental Antiviral Oct/02/2020
L3 Azo imidazole
Potential treatment - theoretical effect Experimental Antiviral Oct/02/2020
Celgosivir
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/26/2020
N-9-Methoxynonyldeoxynojirimycin
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/26/2020
FX06
Potential treatment - clinical evidence Experimental Other treatment Sep/24/2020
Diammonium glycyrrhizinate
Potential treatment - theoretical effect Experimental Antiviral Sep/24/2020
Ridogrel
Potential treatment - theoretical effect Experimental Antiviral Sep/23/2020
4-Chloro-N-[1-(2-quinolin-3-ylethynyl)cyclohexyl]-1H-pyrazole-5-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Sep/21/2020
5-[2-(3-Chlorophenoxy)ethyl]-3-[(2R)-1-pyrrolidin-1-ylsulfonylpyrrolidin-2-yl]-1H-pyrazole
Potential treatment - theoretical effect Experimental Antiviral Sep/21/2020
2-Chloro-N-(4-methylsulfonylphenyl)sulfonyl-5-pyrazol-1-ylbenzamide
Potential treatment - theoretical effect Experimental Antiviral Sep/21/2020
AR-12
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/20/2020
2.4.1.5. 1-[2-(2‑hydroxy-3‑methoxy-5-(4-carboxyphenylazo) benzaldeneamino)ethyl]−3-methyl-3H-imidazole-3-ium hexafluorophosphate
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
Anti-SARS-CoV-2 monobody clone 6b
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/18/2020
Bedoradrine
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020